Search
Search
About
Log in
Join
Experiences with
Alunbrig
Posts
Communities
2 public posts
Filter results
FDA Approves Brigatinib for ALK-positive Metastatic NSCLC
In addition to the approval for
Alunbrig
(brigatinib), the FDA has approved the Vysis ALK Break Apart FISH Probe as a companion diagnostic for
Alunbrig
(brigatinib).
In addition to the approval for
Alunbrig
(brigatinib), the FDA has approved the Vysis ALK Break Apart FISH Probe as a companion diagnostic for
Alunbrig
(brigatinib).
Miranda_GO2
Partner
in
Lung Cancer Support
4 years ago
A new drug for ALK-positive lung cancer approved today
The drug is called brigatinib (brand name:
Alunbrig
) and is approved for treatment of patients whose tumor has the ALK mutation. Brigatinib is to be used after another drug targeting ALK stops working.
The drug is called brigatinib (brand name:
Alunbrig
) and is approved for treatment of patients whose tumor has the ALK mutation. Brigatinib is to be used after another drug targeting ALK stops working.
MFH_Advocate
in
Lung Cancer Support
7 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Filter results
Clear filters
Posted in
All communities
Lung Cancer Support
2 results
Sort by
Most Relevant
Newest